Confirmation of 5p12 as a susceptibility locus for progesterone-receptor- positive, lower grade breast cancer

Cancer Epidemiology Biomarkers and Prevention

Volumn 20, Issue 10, 2011, Pages 2222-2231

  Milne, Roger L ^a,c   Goode, Ellen L ^e   García Closas, Montserrat ^f   Couch, Fergus J ^e   Severi, Gianluca ^c,d   Hein, Rebecca ⁱ   Fredericksen, Zachary ^e   Malats, Núria ^a   Zamora, M Pilar ^b   Pérez, Jose Ignacio Arias ^j   Benítez, Javier ^a   Dörk, Thilo ^k   Schürmann, Peter ^k   Karstens, Johann H ^k   Hillemanns, Peter ^k   Cox, Angela ^l   Brock, Ian W ^l   Elliot, Graeme ^l,m   Cross, Simon S ^l   Seal, Sheila ^f   Turnbull, Clare ^f   Renwick, Anthony ^f   Rahman, Nazneen ^f   Shen, Chen Yang ⁿ   Yu, Jyh Cherng ^o   Huang, Chiun Sheng ^p   Hou, Ming Feng ^q   Nordestgaard, Børge G ^r   Bojesen, Stig E ^r   Lanng, Charlotte ^s   Alnæs, Grethe Grenaker ^t   Kristensen, Vessela ^t,u   Børrensen Dale, Anne Lise ^t,u   Hopper, John L ^c   Dite, Gillian S ^c   Apicella, Carmel ^c   Southey, Melissa C ^c   Lambrechts, Diether ^v   Yesilyurt, Betül T ^v   Floris, Giuseppe ^w   Leunen, Karin ^w   Sangrajrang, Suleeporn ^x   Gaborieau, Valerie ^y   Brennan, Paul ^y   McKay, James ^y   Chang Claude, Jenny ^i,z   Wang Gohrke, Shan ^z   Radice, Paolo ^aa,ab   Peterlongo, Paolo ^aa,ab   Manoukian, Siranoush ^aa   Barile, Monica ^ac   Giles, Graham G ^c,d   Baglietto, Laura ^c,d   John, Esther M ^ad   Miron, Alexander ^ae   Chanock, Stephen J ^ah   Lissowska, Jolanta ^ai   Sherman, Mark E ^ah   Figueroa, Jonine D ^ah   Bogdanova, Natalia V ^k   Antonenkova, Natalia N ^ak   Zalutsky, Iosif V ^ak   Rogov, Yuri I ^ak   Fasching, Peter A ^al,an   Bayer, Christian M ^al   Ekici, Arif B ^am   Beckmann, Matthias W ^al   Brenner, Hermann ⁱ   Müller, Heiko ⁱ   Arndt, Volker ⁱ   Stegmaier, Christa ^ao   Andrulis, Irene L ^ap,ar   Knight, Julia A ^ap,aq   Glendon, Gord ^ap   Mulligan, Anna Marie ^ar,as   Mannermaa, Arto ^at,au   Kataja, Vesa ^at,au   Kosma, Veli Matti ^at,au   Hartikainen, Jaana M ^at,au   Meindl, Alfons ^av   Heil, Joerg ⁱ   Bartram, Claus R ⁱ   Schmutzler, Rita K ^aw   Thomas, Gilles D ^ah   Hoover, Robert N ^ah   Fletcher, Olivia ^f   Gibson, Lorna J ^g   Dos Santos Silva, Isabel ^g   Peto, Julian ^g   Nickels, Stefan ⁱ   Flesch Janys, Dieter ^ax   Anton Culver, Hoda ^ay   Ziogas, Argyrios ^ay   Sawyer, Elinor ^h   Tomlinson, Ian ^az   Kerin, Michael ^ba   Miller, Nicola ^ba   Schmidt, Marjanka K ^bb   Broeks, Annegien ^bb   Van't Veer, Laura J ^bb   Tollenaar, Rob A E M ^bc   Pharoah, Paul D P ^bd   Dunning, Alison M ^bd   Pooley, Karen A ^bd   Marme, Frederik ⁱ   Schneeweiss, Andreas ⁱ   Sohn, Christof ⁱ   Burwinkel, Barbara ⁱ   Jakubowska, Anna ^be   Lubinski, Jan ^be   Jaworska, Katarzyna ^aj,be   Durda, Katarzyna ^be   Kang, Daehee ^bf   Yoo, Keun Young ^bf   Noh, Dong Young ^bf   Ahn, Sei Hyun ^bg   Hunter, David J ^ae,af   Hankinson, Susan E ^af,ag   Kraft, Peter ^ae,af   Lindstrom, Sara ^ae,af   Chen, Xiaoqing ^bh   Beesley, Jonathan ^bh   Hamann, Ute ⁱ   Harth, Volker ^bi   Justenhoven, Christina ^bj,bk   Winqvist, Robert ^bl   Pylkäs, Katri ^bl   Jukkola Vuorinen, Arja ^bl   Grip, Mervi ^bm   Hooning, Maartje ^bn   Hollestelle, Antoinette ^bo   Oldenburg, Rogier A ^bn   Tilanus Linthorst, Madeleine ^bn   Khusnutdinova, Elza ^bp   Bermisheva, Marina ^bp   Prokofieva, Darya ^bp   Farahtdinova, Albina ^bp   Olson, Janet E ^e   Wang, Xianshu ^e   Humphreys, Manjeet K ^bd   Wang, Qin ^bd   Chenevix Trench, Georgia ^bh   Easton, Douglas F ^bd   more..

^a Centro Nacional de Investigaciones Oncológicas   (Spain)

^b HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d CANCER EPIDEMIOLOGY CENTRE   (Australia)

^e MAYO CLINIC   (United States)

^f INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^g LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^h GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

ⁱ UNIVERSITY OF HEIDELBERG   (Germany)

^j HOSPITAL MONTE NARANCO   (Spain)

^k HANNOVER MEDICAL SCHOOL   (Germany)

^l UNIVERSITY OF SHEFFIELD   (United Kingdom)

^m UNIVERSITY OF MANCHESTER   (United Kingdom)

ⁿ INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^o TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^p NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^q KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^r Mental Health Services CPH   (Denmark)

^s GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^t OSLO UNIVERSITY HOSPITAL   (Norway)

^u UNIVERSITY OF OSLO   (Norway)

^v DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^w UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^x NATIONAL CANCER INSTITUTE   (Thailand)

^y INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^z UNIVERSITY OF ULM   (Germany)

^aa NATIONAL CANCER INSTITUTE   (Italy)

^ab FIRC INSTITUTE OF MOLECULAR ONCOLOGY   (Italy)

^ac EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^ad STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^ae HARVARD MEDICAL SCHOOL   (United States)

^af HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^ag BRIGHAM AND WOMEN S HOSPITAL   (United States)

^ah NATIONAL CANCER INSTITUTE   (United States)

^ai INSTITUTE OF ONCOLOGY   (Poland)

^aj MEDICAL UNIVERSITY OF WARSAW   (Poland)

^ak Research Institute of Oncology and Medical Radiology of the Ministry of Health of the Byelorussian SSR   (Belarus)

^al UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^am UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^an UNIVERSITY OF CALIFORNIA   (United States)

^ao SAARLAND CANCER REGISTRY   (Germany)

^ap UNIVERSITY OF TORONTO   (Canada)

^aq MOUNT SINAI HOSPITAL   (Canada)

^ar UNIVERSITY OF TORONTO   (Canada)

^as ST MICHAEL'S HOSPITAL   (Canada)

^at UNIVERSITY OF EASTERN FINLAND   (Finland)

^au KUOPIO UNIVERSITY HOSPITAL   (Finland)

^av TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^aw UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^ax UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^ay UNIVERSITY OF CALIFORNIA   (United States)

^az UNIVERSITY OF OXFORD   (United Kingdom)

^ba UNIVERSITY HOSPITAL GALWAY   (Ireland)

^bb ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

^bc LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^bd UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^be POMERANIAN MEDICAL UNIVERSITY   (Poland)

^bf Seoul National University College of Medicine   (South Korea)

^bg University of Ulsan College of Medicine   (South Korea)

^bh QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^bi INSTITUT DER RUHR UNIVERSITÄT BOCHUM IPA   (Germany)

^bj DR MARGARETE FISCHER BOSCH INSTITUTE OF CLINICAL PHARMACOLOGY   (Germany)

^bk UNIVERSITY OF TÜBINGEN   (Germany)

^bl UNIVERSITY OF OULU   (Finland)

^bm OULU UNIVERSITY HOSPITAL   (Finland)

^bn ERASMUS MEDICAL CENTER   (Netherlands)

^bo JOSEPHINE NEFKENS INSTITUTE   (Netherlands)

^bp INSTITUTE OF BIOCHEMISTRY AND GENETICS   (Russian Federation)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AGED; ALLELE; ARTICLE; ASIAN; BREAST CANCER; CANCER GRADING; CANCER INVASION; CANCER RISK; CHROMOSOME 5P; EUROPEAN AMERICAN; FEMALE; GENE LOCUS; GENETIC SUSCEPTIBILITY; HISTOPATHOLOGY; HUMAN; INTRADUCTAL CARCINOMA; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 80053517824     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-11-0569     Document Type: Article

References (13)

1. Ahmed S, Thomas G, Ghoussaini M, Healey CS, Humphreys MK, Platte R, et al. Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. Nat Genet 2009;41:585-90.
2. Easton DF, Pooley KA, Dunning AM, Pharoah PD, Thompson D, Ballinger DG, et al. Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 2007;447:1087-93. (Pubitemid 47014426)
3. Hunter DJ, Kraft P, Jacobs KB, Cox DG, Yeager M, Hankinson SE, et al. A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet 2007;39:870-4. (Pubitemid 47014500)
4. Stacey SN, Manolescu A, Sulem P, Rafnar T, Gudmundsson J, Gudjonsson SA, et al. Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer. Nat Genet 2007;39:865-9. (Pubitemid 47014497)
5. Stacey SN, Manolescu A, Sulem P, Thorlacius S, Gudjonsson SA, Jonsson GF, et al. Common variants on chromosome 5p12 confer susceptibility to estrogen receptor-positive breast cancer. Nat Genet 2008;40:703-6. (Pubitemid 351748861)
6. StataCorp. Stata statistical software: release 10.0. College Station, TX: Stata Corp LP; 2007.
7. Long J, Shu XO, Cai Q, Gao YT, Zheng Y, Li G, et al. Evaluation of breast cancer susceptibility loci in Chinese women. Cancer Epidemiol Biomarkers Prev 2010;19:2357-65.
8. Kraft P. Curses-winner's and otherwise-in genetic epidemiology. Epidemiology 2008;19:649-51; discussion 657-8.
9. Thomas G, Jacobs KB, Kraft P, Yeager M, Wacholder S, Cox DG, et al. A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1). Nat Genet 2009;41: 579-84.
10. Broeks A, Schmidt MK, Sherman ME, Couch FJ, Hopper JL, Dite GS, et al. Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium. Hum Mol Genet 2011;20:3289-303.
11. Reeves GK, Travis RC, Green J, Bull D, Tipper S, Baker K, et al. Incidence of breast cancer and its subtypes in relation to individual and multiple low-penetrance genetic susceptibility loci. JAMA 2010;304:426-34.
12. Cavdar Koc E, Burkhart W, Blackburn K, Moseley A, Spremulli LL. The small subunit of the mammalian mitochondrial ribosome. Identification of the full complement of ribosomal proteins present. J Biol Chem 2001;276:19363-74.
13. Theodorou V, Boer M, Weigelt B, Jonkers J, Van der Valk M, Hilkens J. Fgf10 is an oncogene activated by MMTV insertional mutagenesis in mouse mammary tumors and overexpressed in a subset of human breast carcinomas. Oncogene 2004;23:6047-55. (Pubitemid 39178857)